FIELD: medicine.
SUBSTANCE: invention refers to the use of binuclear sulphur-nitrosyl iron complex of formula [Fe2(SC5H11NO2)2(NO)4]·5H2O as a vasodilatator and for preparing a therapeutic agent for ischemic diseases.
EFFECT: invention provides extended range of vasodilatators with improved cardiotropic activity.
2 cl, 10 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF BINUCLEAR SULPHUR-NITROSYL COMPLEX OF ANION TYPE IRON AS VASODEPRESSOR MEDICATION | 2010 |
|
RU2437667C1 |
| WATER-SOLUBLE BINUCLEAR CATION NITROSYL IRON COMPLEXES WITH NATURAL ALIPHATIC THIOLYLS POSSESSING CYTOTOXIC, APOPTOTIC AND NO-DONOR ACTIVITY | 2008 |
|
RU2441873C2 |
| BINUCLEAR NITROSYL IRON COMPLEXES WITH BENZAZEHETEROCYCLIC DERIVATIVES, WAYS OF ITS PRODUCTION | 2007 |
|
RU2441872C2 |
| USING TETRANITROSYL COMPLEX OF IRON WITH THIOPHENOL AS ANTI-TUMOUR MEDICINAL AGENT | 2007 |
|
RU2429242C2 |
| MONONECLEAR DINITROSYL FERRIC COMPLEXES, METHOD FOR PREPARING MONONECLEAR DINITROSYL FERRIC COMPLEXES, NITROGEN MONOXIDE DONOR, USING MONONECLEAR DINITROSYL FERRIC COMPLEXES AS ANTI-TUMOUR DRUG | 2011 |
|
RU2494104C2 |
| SINGLE-NUCLEAR CATIONIC DINITROSYL IRON COMPLEXES, METHOD FOR PRODUCING THEM, NITROGEN MONOXIDE DONOR | 2014 |
|
RU2567245C1 |
| SUPRAMOLECULAR ASSEMBLIES OF DINITROSYL IRON COMPLEXES, METHOD OF THEIR PREPARATION, NITROGEN MONOXIDE DONORS, PHOSPHODIESTERASE INHIBITORS, USE OF SUPRAMOLECULAR ASSEMBLIES OF DINITROSYL IRON COMPLEXES AS ANTI-INFLAMMATORY MEDICINAL PRODUCTS | 2023 |
|
RU2814108C1 |
| APPLICATION OF DINITROSYL IRON COMPLEX WITH GLUTATHIONE-GS {(GS)2FE2(NO)4} FOR THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION | 2022 |
|
RU2804734C1 |
| USE OF NITROSYL IRON COMPLEX WITH N,N-DIETHYLTHIOUREA AS NEW NO-DONOR ANTICANCER AGENT | 2016 |
|
RU2687269C2 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 AND METHOD OF USING THE SAME | 2022 |
|
RU2797619C1 |
